{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:21:49Z","timestamp":1760898109380},"publisher-location":"Berlin, Heidelberg","reference-count":37,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642847479"},{"type":"electronic","value":"9783642847455"}],"license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/978-3-642-84745-5_34","type":"book-chapter","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T21:46:03Z","timestamp":1323294363000},"page":"257-266","source":"Crossref","is-referenced-by-count":12,"title":["Long-Term Toxicity of Tamoxifen"],"prefix":"10.1007","author":[{"given":"L. E.","family":"Rutqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"34_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Costantino J, Redmond C et al. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479\u2013484","journal-title":"N Engl J Med"},{"key":"34_CR2","doi-asserted-by":"crossref","unstructured":"Fornander T, Rutqvist LE, Wilking N, Carlstr\u00f6m K, van Schoultz B (1992) Estrogenic effecs of adjuvant tamoxifen in postmenopausal breast cancer. Eur J Cancer (in press)","DOI":"10.1016\/S0959-8049(05)80138-8"},{"key":"34_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0021-9150(84)90064-9","volume":"52","author":"S R\u00f6ssner","year":"1984","unstructured":"R\u00f6ssner S, Wallgren A (1984) Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis 52:339\u2013346","journal-title":"Atherosclerosis"},{"key":"34_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.1990.8.6.1019","volume":"8","author":"T Fornander","year":"1990","unstructured":"Fornander T, Rutqvist LE, Sj\u00f6berg HE, Blomqvist L, Mattsson A, Glas U (1990) Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women. J Clin Oncol 8:1019\u20131024","journal-title":"J Clin Oncol"},{"key":"34_CR5","first-page":"51","volume-title":"Medical management of breast cancer","author":"IM Jackson","year":"1991","unstructured":"Jackson IM, Litherland S, Wakeling AE (1991) Tamoxifen and other antiestrogens. In: Powles TJ, Smith IE (eds) Medical management of breast cancer Cambridge University Press, Cambridge, pp 51\u201359"},{"key":"34_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jama.1980.03300320012005","volume":"243","author":"A Hendrick","year":"1980","unstructured":"Hendrick A, Subramanian VP (1980) Tamoxifen and thrombembolism JAMA 243:514\u2013515","journal-title":"JAMA"},{"key":"34_CR7","first-page":"887","volume":"68","author":"A Lipton","year":"1984","unstructured":"Lipton A, Harvey HA, Hamilton RW (1984) Venous thrombosis as a side effect of tamoxifen treatment. Cancer Treat Rep 68:887\u2013889","journal-title":"Cancer Treat Rep"},{"key":"34_CR8","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(78)91668-9","volume":"2","author":"K Nevasaari","year":"1978","unstructured":"Nevasaari K, Heikkinen M, Taskinen PJ (1978) Tamoxifen and thrombosis. Lance 2:946\u2013947","journal-title":"Lance"},{"key":"34_CR9","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/1097-0142(19840615)53:12<2607::AID-CNCR2820531206>3.0.CO;2-T","volume":"53","author":"RE Enck","year":"1984","unstructured":"Enck RE, Rios CN (1984) Tamoxifen treatment of metastatic breast cancer and antithrombin-III levels. Cancer 53:2607\u20132609","journal-title":"Cancer"},{"key":"34_CR10","first-page":"60","volume":"7","author":"K Rieche","year":"1986","unstructured":"Rieche K (1986) Die Beeinflussung des funktioneilen Antithrombin III im plasma durch Tamoxifen und Aminoglutethemid. Krebsmedizin 7:60\u201363","journal-title":"Krebsmedizin"},{"key":"34_CR11","first-page":"4517","volume":"47","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Fritz NF, Tormey DC (1987) Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III. Cancer Res 47:4517\u20134519","journal-title":"Cancer Res"},{"key":"34_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/1097-0142(19880401)61:7<1316::AID-CNCR2820610707>3.0.CO;2-5","volume":"61","author":"MJ Auger","year":"1988","unstructured":"Auger MJ, Mackie MJ (1988) Effects of tamoxifen on blood coagulation. Cancer 61:1316\u20131319","journal-title":"Cancer"},{"key":"34_CR13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","volume":"9","author":"T Saphnerr","year":"1991","unstructured":"Saphnerr T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9: 286\u2013294","journal-title":"J Clin Oncol"},{"key":"34_CR14","first-page":"159","volume":"19","author":"E Barrett-Connor","year":"1989","unstructured":"Barrett-Connor E, Bush TL (1989) Estrogen replacement therapy and coronary heart disease. Cardiovasc Clin 19:159\u2013172","journal-title":"Cardiovasc Clin"},{"key":"34_CR15","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/jnci\/82.16.1327","volume":"82","author":"RR Love","year":"1990","unstructured":"Love RR, Newcomb PA, Wiebe DA et al. (1990) Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst 82:1327\u20131332","journal-title":"J Natl Cancer Inst"},{"key":"34_CR16","first-page":"171","volume":"2","author":"Breast Cancer Trials Comittee, Scottish Cancer Trials Office","year":"1987","unstructured":"Breast Cancer Trials Comittee, Scottish Cancer Trials Office (1987) Adjuvant tamoxifen in the mangement of operable breast cancer: the Scottish trial. Lancet 2:171\u2013175","journal-title":"Lancet"},{"key":"34_CR17","doi-asserted-by":"crossref","unstructured":"Rutqvist LE, Cedermark B, Glas U et al. (1992) Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Acta Oncol (in press)","DOI":"10.3109\/02841869209088913"},{"key":"34_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy, 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 339:1\u201315, 71\u201385","journal-title":"Lancet"},{"key":"34_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000225571","volume":"38","author":"F Boccardo","year":"1981","unstructured":"Boccardo F, Bruzzi P, Rubagotti A, Nicolo G, Rosso R (1981) Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 38:281\u2013285","journal-title":"Oncology"},{"key":"34_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0020-7292(91)90767-Y","volume":"36","author":"X Muylder De","year":"1991","unstructured":"De Muylder X, Neven P, de Somer M et al. (1991) Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynaecol Obstet 36:127\u2013130","journal-title":"Int J Gynaecol Obstet"},{"key":"34_CR21","first-page":"4006","volume":"44","author":"PG Satyaswaroop","year":"1984","unstructured":"Satyaswaroop PG, Zaino RJ, Marbel R (1984) Estrogen-like effecs of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 44:4006\u20134010","journal-title":"Cancer Res"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"1","author":"T Fornander","year":"1989","unstructured":"Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversw\u00e4rd C, Skoog L, Somell A, Theve T, Wilking N, Askergren J, Hjalmar ML (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1:117\u2013120","journal-title":"Lancet"},{"key":"34_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/jnci\/83.14.1013","volume":"83","author":"M Andersson","year":"1991","unstructured":"Andersson M, Storm HH, Mouridsen HT (1991) Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83:1013\u20131017","journal-title":"J Natl Cancer Inst"},{"key":"34_CR24","doi-asserted-by":"crossref","unstructured":"Ryd\u00e9n S, Fern\u00f6 M, M\u00f6ller T et al. (1992) Long-term effects of adjuvant tamoxifen and\/or radiotherapy. The South Sweden Trial. Acta Oncol (in press)","DOI":"10.3109\/02841869209088914"},{"key":"34_CR25","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S0140-6736(87)91491-7","volume":"2","author":"IS Fentiman","year":"1987","unstructured":"Fentiman IS, Powles TJ (1987) Tamoxifen and benign breast problems. Lancet 2:1070\u20131072","journal-title":"Lancet"},{"key":"34_CR26","volume-title":"Tamoxifen vs chemotherapy vs chemotherapy plus tamoxifen in stage II ER+ breast cancer patients. Preliminary results of the GROCTA trials (Abstr)","author":"F Boccardo","year":"1989","unstructured":"Boccardo F, Rubagotti A, Bruzzi P et al. (1989) Tamoxifen vs chemotherapy vs chemotherapy plus tamoxifen in stage II ER+ breast cancer patients. Preliminary results of the GROCTA trials (Abstr). Proceedings of the 5th European Conference on Clinical Oncology (ECCO-5): Federation of European Cancer Societies, London"},{"key":"34_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/bjc.1989.235","volume":"60","author":"TJ Powles","year":"1989","unstructured":"Powles TJ, Hardy JR, Ashley SE et al. (1989) A pilot trial to evaluate the acute toxicity and feasability of tamoxifen for prevention of breast cancer. Br J Cancer 60:126\u2013131","journal-title":"Br J Cancer"},{"key":"34_CR28","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJM198011203032102","volume":"303","author":"NS Weiss","year":"1980","unstructured":"Weiss NS, Ure CL, Ballard JH et al. (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195\u20131198","journal-title":"N Engl J Med"},{"key":"34_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF01811242","volume":"12","author":"RR Love","year":"1988","unstructured":"Love RR, Mazess RB, Tormey DC et al. (1988) Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat 12:297\u2013301","journal-title":"Breast Cancer Res Treat"},{"key":"34_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO;2-I","volume":"61","author":"AR Ashford","year":"1988","unstructured":"Ashford AR, Donev I, Tiwari RP, Garret TJ (1988) Reversible ocular toxicity related to tamoxifen therapy. Cancer 61:33\u201335","journal-title":"Cancer"},{"key":"34_CR31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0161-6420(81)35071-4","volume":"8","author":"MI Kaiser-Kupfer","year":"1981","unstructured":"Kaiser-Kupfer MI, Kupfer C, Rodrigues MM (1981) Tamoxifen retinopathy: a clinicopathologic report. Ophtalmology 8:89\u201393","journal-title":"Ophtalmology"},{"key":"34_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0002-9394(87)90014-6","volume":"104","author":"MF Griffiths","year":"1987","unstructured":"Griffiths MF (1987) Tamoxifen retinopathy at low dosage. Am J Ophtalmol 104:185\u2013186","journal-title":"Am J Ophtalmol"},{"key":"34_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1755-3768.1983.tb01393.x","volume":"61","author":"T Vinding","year":"1983","unstructured":"Vinding T, Nielsen NV (1983) Retinopathy caused by treatment with tamoxifen in low dosage. Acta Ophtalmol (Lopenh) 61:45\u201350","journal-title":"Acta Ophtalmol (Lopenh)"},{"key":"34_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0022-4731(88)90113-6","volume":"30","author":"MM Gottardis","year":"1988","unstructured":"Gottardis MM, Robinson SP, Jordan VC (1988) Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen. J Steroid Biochem 30:311\u2013314","journal-title":"J Steroid Biochem"},{"key":"34_CR35","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jnci\/83.20.1477","volume":"83","author":"CK Osborne","year":"1991","unstructured":"Osborne CK, Coronado E, Allred DC et al. (1991) Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J Natl Cancer Inst 83:1477\u20131482","journal-title":"J Natl Cancer Inst"},{"key":"34_CR36","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/bjc.1988.137","volume":"57","author":"WP Abram","year":"1988","unstructured":"Abram WP, Baum M, Berstock DA et al. (1988) Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. Preliminary analysis by the CRC Adjuvant Breast Trial Working Party. Br J Cancer 57:604\u2013607","journal-title":"Br J Cancer"},{"key":"34_CR37","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/jnci\/83.18.1299","volume":"83","author":"LE Rutqvist","year":"1991","unstructured":"Rutqvist LE, Cedermark B, Glas U et al. (1991) Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 83:1299\u20131306","journal-title":"J Natl Cancer Inst"}],"container-title":["Recent Results in Cancer Research","Adjuvant Therapy of Breast Cancer IV"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-84745-5_34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T14:49:27Z","timestamp":1558190967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-84745-5_34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"ISBN":["9783642847479","9783642847455"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-84745-5_34","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1993]]}}}